Melphalan, Prednisone

Views Updated: Dec 15, 2025

Abbreviation

Pronunciation

/melˈfælən, ˈprednɪsəʊn/

Adverse events were consistent with established profiles of toxic events associated with bortezomib and melphalan – prednisone.
Background The standard treatment for patients with multiple myeloma who are not candidates for high-dose therapy is melphalan and prednisone.
The standard conventional therapy is the combination of melphalan and prednisone resulting in a response rate of 40 % - 60 % and in a median survival time of approximately 3 years.

Monetary Policy Business

Multiprocessing Computing

Moving Picture Community

Motion Picture Community

Multi Processing Computing

Master Piece Misc

Media Player Community

Members of Parliament, UK Regional

Menstrual Period Medical

Multi Processor Computing